Related Experiment Video
Updated: Jun 17, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
COVID-19 vaccination and postmenopausal bleeding: a retrospective cohort study
Lucía Pastor-Goutherot1, Ester Miralpeix1,2, Berta Fabregó2
1Pompeu Fabra University, Barcelona, Spain.
Insights
COVID-19 vaccination is linked to a higher prevalence of postmenopausal bleeding (PMB). However, the vaccine did not increase endometrial cancer risk, though endometrial biopsy is recommended for any PMB.
Area of Science:
- Gynecology
- Reproductive Health
- Vaccinology
Background:
- Menstrual irregularities have been reported following COVID-19 vaccination.
- The impact of COVID-19 vaccination on postmenopausal women, specifically regarding postmenopausal bleeding (PMB), remains largely unknown.
- Understanding potential side effects of widespread vaccination programs is crucial for public health.
Purpose of the Study:
- To investigate the prevalence of postmenopausal bleeding (PMB) in women after receiving COVID-19 vaccination.
- To analyze the association between COVID-19 vaccination and the occurrence of PMB in a postmenopausal cohort.
- To evaluate endometrial pathology in relation to vaccination status and PMB.
Main Methods:
- A retrospective study included 381 postmenopausal women, categorized into vaccinated (n=91) and unvaccinated (n=290) groups.
- Data were collected between February 2021 and January 2022, with PMB defined as bleeding occurring more than 30 days post-vaccination.
- Statistical analyses, including univariable and multivariable regression, were performed to identify risk factors for PMB.
Main Results:
- The prevalence of PMB was significantly higher in the vaccinated group (75.8%) compared to the unvaccinated group (59.0%) (p < 0.005).
- No statistically significant increase in malignant endometrial pathology was observed in the vaccinated group (p = 0.189).
- Multivariable analysis identified COVID-19 vaccination and malignant endometrial biopsy as independent risk variables for PMB.
Conclusions:
- COVID-19 vaccination is associated with an increased prevalence of postmenopausal bleeding.
- While vaccination did not correlate with an increased risk of malignant endometrial pathology, PMB necessitates further investigation.
- Endometrial biopsy remains a critical diagnostic tool for evaluating postmenopausal bleeding, irrespective of vaccination status.
Objective:
COVID-19 vaccination has been related to menstrual irregularities; however, the effect on postmenopausal women is unknown. The aim of this study was to analyze the prevalence of postmenopausal bleeding (PMB) after COVID-19 vaccination.
Methods:
A retrospective study was conducted in the Department of Gynecology in Hospital del Mar. Consecutive postmenopausal women with data available and endometrial biopsy were included between February 2021 and January 2022. Patients were stratified between COVID-19 vaccinated and unvaccinated groups. PMB after 30 days from last vaccine dose was considered unrelated to vaccine. Endometrial pathology diagnoses were stratified into benign or malignant. Univariable and multivariable of regression analysis on variables potentially associated with PMB was performed.
Results:
A total of 381 patients were included, 91 in the vaccinated group and 290 in the unvaccinated group. Prevalence of PMB in the vaccinated group was 75.8% compared to 59.0% in the unvaccinated group (p < 0.005). No increase in endometrial malignant pathology was observed among the vaccinated group (p = 0.189). Multivariable analysis that correlates factors associated with PMB suggests COVID-19 vaccine and malignant endometrial biopsy as independent risk variables.
Conclusions:
A higher prevalence of PMB was associated with COVID-19 vaccine. Endometrial histological results showed no association with COVID-19 vaccination, but endometrial biopsy should be performed for PMB.
More Related Videos
Related Concept Videos
Menopause
Disorders of the Female Reproductive System
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

